Drug profile · INN
pegademase bovine
ADAGEN
pegademase bovine (ADAGEN) is a 2'-deoxyadenosine hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
Drug details — pegademase bovine
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
pegademase bovine (ADAGEN) is a 2'-deoxyadenosine hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
2'-deoxyadenosine hydrolytic enzyme
Primary target: 2'-deoxyadenosine
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is pegademase bovine?
pegademase bovine (ADAGEN) is a 2'-deoxyadenosine hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for pegademase bovine?
ADAGEN is a marketed brand name for pegademase bovine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pegademase bovine?
pegademase bovine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.